About Congenital myasthenic syndrome with glycosylation defect
Congenital myasthenic syndrome with glycosylation defect is a rare disease catalogued by Orphanet (ORPHA:353327). It is associated with the ALG2, DPAGT1, GFPT1 genes. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Congenital myasthenic syndrome with glycosylation defect trials.
Search ClinicalTrials.gov for "Congenital myasthenic syndrome with glycosylation defect" or filter by Orphanet code ORPHA:353327 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Congenital myasthenic syndrome with glycosylation defect trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Congenital myasthenic syndrome with glycosylation defect. Updated daily.